Evercore ISI has upgraded Cardinal Health (NYSE:CAH) to outperform from in line, citing the company's improved outlook. The investment firm said it sees FY'25 pharma AOI guidance as conservative, with ...

Evercore ISIS issued a cautious outlook on the food sector for 2025, with just a few names slotted with bull ratings. The ...

Consider investing in companies like Evercore with exposure to large ticket transactions post-Trump victory, despite caution ...

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Evercore ISI analyst David Palmer maintained a Buy rating on Mondelez International (MDLZ – Research Report) today and set a price target of ...

Micron Technologies (MU) is climbing for a second straight day after Nvidia (NVDA) noted that it was using MU’s chips in its ...

Europe’s automakers face existential threats from EU CO2 rules, China competition, weak sales and factory closures. The ...

Tidal Partners, a mergers and acquisitions advisory firm launched in 2022 by former Centerview Partners dealmakers, has hired investment banker Anand Sankaralingam from Evercore , according to people ...

Evercore ISI raised the firm’s price target on Zimmer Biomet (ZBH) to $113 from $110 and keeps an In Line rating on the ...

Evercore examined Microsoft's past performance as well, noting four times over the past four years when the company lagged ...

Evercore ISI upgraded Cardinal Health (CAH) to Outperform from In Line with an unchanged price target of $140. The firm sees the company’s ...